证券记录 · 已归档季度
SOLV
Solventum Corporation · Healthcare · Medical - Instruments & Supplies
22被追踪持有人
+1Δ持有人
55.78M持有股份
$4.07B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +4.8% ·
股份流向 +5.2% ·
净新建仓位 0.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 555.50K | $48.88M | n/a | −1 |
| Q2 2026 | 149 | +2 | 80.14M | $6.18B | +13 | −12 |
| Q1 2026 | 151 | -8 | 79.93M | $5.22B | +3 | −12 |
| Q4 2025 | 158 | +1 | 87.71M | $6.95B | +3 | −1 |
| Q3 2025 | 22 | +1 | 55.78M | $4.07B | +1 | −1 |
| Q2 2025 | 19 | 0 | 51.64M | $3.92B | +2 | −2 |
| Q1 2025 | 16 | -1 | 25.10M | $1.91B | +1 | −2 |
| Q4 2024 | 17 | -2 | 26.13M | $1.73B | +2 | −4 |
| Q3 2024 | 18 | +2 | 20.00M | $1.39B | +4 | −2 |
| Q2 2024 | 16 | n/a | 16.58M | $874.59M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 17.12M | +5.3% | $1.25B | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 10.23M | +6.1% | $746.99M | 0.0% | ▲ Add | 2 | SEC ↗ ×21 |
| 3 | Trian Fund Management ✦ | 8.46M | 0.0% | $617.79M | 15.0% | Held | 6 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (被动) | 6.22M | +1.8% | $454.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 3.83M | +7.3% | $278.09M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 1.91M | +38.2% | $139.35M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 7 | Citadel Advisors ✦ | 1.56M | +106.8% | $113.56M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 1.47M | n/a | $107.15M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 9 | JPMorgan Chase ✦ | 1.37M | n/a | $100.21M | 0.0% | n/c | 1 | SEC ↗ ×28 |
| 10 | Arrowstreet Capital ✦ | 1.17M | -11.1% | $85.69M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 11 | Millennium Management ✦ | 677.85K | +12.7% | $49.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 405.08K | n/a | $29.57M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | Adage Capital Partners ✦ | 292.62K | +39.2% | $21.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 257.85K | -67.0% | $18.75M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 15 | T. Rowe Price ✦ | 215.91K | +7.4% | $15.76M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 16 | Marshall Wace ✦ | 157.67K | +1461.4% | $11.51M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 17 | Renaissance Technologies ✦ | 151.80K | +351.8% | $11.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 135.37K | -38.2% | $9.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 54.69K | 新增 | $3.99M | 0.0% | New | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 43.13K | -79.1% | $3.15M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 21 | Wellington Management ✦ | 29.89K | +7.1% | $2.18M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 22 | GAMCO Investors ✦ | 12.83K | +2.0% | $936,298 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Bridgewater Associates | $3.99M | 0.0% |
已清仓
| Norges Bank | $140.49M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 873 持有人, 128.07M 股份, $8.18B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据